AstraZeneca shares rose nearly 5 percent on Wednesday after the group won a key U.S. patent battle over its second-biggest selling drug, Seroquel, for schizophrenia and bipolar disorder.
Read full story
AstraZeneca bolstered by Seroquel patent victoryPosted by UK Economy News
In UK financial news
2Jul 08 No Comments Yet - You can be the first to comment!Sorry, comments for this entry are closed at this time. |
|
Subscribe to RSS
